132 related articles for article (PubMed ID: 35034110)
21. Endoscopic follow-up of Barrett's esophagus: protocol and implications.
De Looze D
Acta Gastroenterol Belg; 2000; 63(1):29-35. PubMed ID: 10907316
[TBL] [Abstract][Full Text] [Related]
22. Effect of Barrett's esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma.
Grant KS; DeMeester SR; Kreger V; Oh D; Hagen JA; Chandrasoma P; DeMeester TR
J Thorac Cardiovasc Surg; 2013 Jul; 146(1):31-7. PubMed ID: 23312980
[TBL] [Abstract][Full Text] [Related]
23. A guide for surveillance of patients with Barrett's esophagus.
Provenzale D; Kemp JA; Arora S; Wong JB
Am J Gastroenterol; 1994 May; 89(5):670-80. PubMed ID: 8172136
[TBL] [Abstract][Full Text] [Related]
24. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
Weston AP; Badr AS; Hassanein RS
Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
[TBL] [Abstract][Full Text] [Related]
25. Barrett's esophagus: Macroscopic markers and the prediction of dysplasia and adenocarcinoma.
Hillman LC; Chiragakis L; Clarke AC; Kaushik SP; Kaye GL
J Gastroenterol Hepatol; 2003 May; 18(5):526-33. PubMed ID: 12702044
[TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
[TBL] [Abstract][Full Text] [Related]
27. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions.
Reid BJ; Weinstein WM; Lewin KJ; Haggitt RC; VanDeventer G; DenBesten L; Rubin CE
Gastroenterology; 1988 Jan; 94(1):81-90. PubMed ID: 3335302
[TBL] [Abstract][Full Text] [Related]
28. [Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma].
Incarbone R; Bonavina L; Bassi F; Peracchia A
Chir Ital; 2002; 54(5):591-6. PubMed ID: 12469454
[TBL] [Abstract][Full Text] [Related]
29. A surveillance programme for Barrett's oesophagus in a UK general hospital.
Olithselvan A; Gorard DA; McIntyre AS
Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):305-9. PubMed ID: 17353694
[TBL] [Abstract][Full Text] [Related]
30. Stepwise radiofrequency ablation of Barrett's esophagus preserves esophageal inner diameter, compliance, and motility.
Beaumont H; Gondrie JJ; McMahon BP; Pouw RE; Gregersen H; Bergman JJ; Boeckxstaens GE
Endoscopy; 2009 Jan; 41(1):2-8. PubMed ID: 19160152
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia.
Kahn A; Al-Qaisi M; Kommineni VT; Callaway JK; Boroff ES; Burdick GE; Lam-Himlin DM; Temkit M; Vela MF; Ramirez FC
Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29036431
[TBL] [Abstract][Full Text] [Related]
32. Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus.
Fitzgerald RC; Saeed IT; Khoo D; Farthing MJ; Burnham WR
Dig Dis Sci; 2001 Sep; 46(9):1892-8. PubMed ID: 11575441
[TBL] [Abstract][Full Text] [Related]
33. Ablation of residual Barrett's epithelium after endoscopic resection: a randomized long-term follow-up study of argon plasma coagulation vs. surveillance (APE study).
Manner H; Rabenstein T; Pech O; Braun K; May A; Pohl J; Behrens A; Vieth M; Ell C
Endoscopy; 2014 Jan; 46(1):6-12. PubMed ID: 24353120
[TBL] [Abstract][Full Text] [Related]
34. Safety and efficacy of carbon dioxide cryotherapy for treatment of neoplastic Barrett's esophagus.
Canto MI; Shin EJ; Khashab MA; Molena D; Okolo P; Montgomery E; Pasricha P
Endoscopy; 2015 Jul; 47(7):582-91. PubMed ID: 25826275
[TBL] [Abstract][Full Text] [Related]
35. Outcome of endoscopy surveillance for Barrett's oesophagus.
Bright T; Schloithe A; Bull JA; Fraser RJ; Bampton P; Watson DI
ANZ J Surg; 2009 Nov; 79(11):812-6. PubMed ID: 20078532
[TBL] [Abstract][Full Text] [Related]
36. [Surveillance of patients with Barrett's esophagus].
Endlicher E; Knüchel R; Messmann H
Z Gastroenterol; 2001 Aug; 39(8):593-600. PubMed ID: 11558064
[TBL] [Abstract][Full Text] [Related]
37. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
38. [Barrett's esophagus carcinoma].
Messmann H
Praxis (Bern 1994); 2006 Jun; 95(25-26):1029-35. PubMed ID: 16836063
[TBL] [Abstract][Full Text] [Related]
39. The usefulness of chromoendoscopy with methylene blue in Barrett's metaplasia and early esophageal carcinoma.
Ormeci N; Savas B; Coban S; Palabiyikoğlu M; Ensari A; Kuzu I; Kursun N
Surg Endosc; 2008 Mar; 22(3):693-700. PubMed ID: 17704887
[TBL] [Abstract][Full Text] [Related]
40. Acetic acid chromoendoscopy in Barrett's esophagus surveillance is superior to the standardized random biopsy protocol: results from a large cohort study (with video).
Tholoor S; Bhattacharyya R; Tsagkournis O; Longcroft-Wheaton G; Bhandari P
Gastrointest Endosc; 2014 Sep; 80(3):417-24. PubMed ID: 24713305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]